L. Dechoux et al. / Tetrahedron 59 (2003) 9701–9706
9705
J¼4 Hz, 1H), 3.16 (m, 1H), 3.29 (s, 3H), 4.87–5.02 (m,
2H), 5.77 (m, 1H). 13C NMR (CDCl3): d¼16.7, 23.5, 26.8,
29.2, 34.1, 50.2, 53.1, 56.4, 74.4, 114.5, 138.6.
2.22 (m, 1H), 4.84–4.97 (m, 2H), 5.76 (m, 1H). 13C NMR
(CDCl3): d¼14.0, 23.4, 24.5, 26.0, 28.4, 31.2, 32.1, 32.9,
40.1, 85.4, 114.5, 138.2, 138.5, 141.0.
4.3.6. 2-Methoxy-5-methyl-2-pent-4-enyl-6-oxa-
1
bicyclo[3.1.0]hexane (3f). (Oil, 87%) H NMR (CDCl3):
d¼1.39 (s, 3H), 1.41–1.63 (m, 7H), 1.92 (m, 1H), 2.06 (m,
2H), 3.09 (s, 1H), 3.32 (s, 3H), 4.94–5.04 (m, 2H), 5.79 (m,
1H). 13C NMR (CDCl3): d¼18.1, 22.1, 28.4, 30.1, 33.3,
34.1, 51.6, 61.8, 65.3, 84.3, 114.8, 138.4.
4.4.6. 6-Methoxytricyclo[7.1.0.0.3.5]decan-2-ol (4e). (Oil,
1
37%) H NMR (CDCl3): d¼0.23 (m, 2H), 0.80 (ddd, J¼4,
7.2, 11.2 Hz, 1H), 1.23 (m, 2H), 1.58 (m, 1H), 1.61–1.75
(m, 4H), 1.77–1.93 (m, 3H), 3.14 (s, 3H), 3.40 (dt, J¼2.7,
9.2 Hz, 1H), 4.75 (d, J¼9.2 Hz, OH). 13C NMR (CDCl3):
d¼6.5, 13.7, 18.5, 20.7, 25.1, 26.4, 28.7, 32.9, 51.7, 73.8,
91.5. HRMS calcd for C10H15O2 (Mþ2Me) 167.1072;
found 167.1072.
4.4. A typical experimental procedure is given for
products obtained in entry d, Table 1
4.4.7. 6-But-3-enyl-1-butylcyclohex-2-enol (5e). (Oil,
1
Under Ar, at room temperature n-BuLi (0.69 mL of a 1.6 M
solution in hexanes, 2 equiv.) was added dropwise, over a
period of 20 min, to a stirred solution of 2-but-3-enyl-2-
methoxy-5-methyl-6-oxabicyclo[3.1.0]hexane 3d (0.1 g,
0.55 mmol, 1 equiv.) in 11 mL of anhydrous pentane. The
mixture was stirred at room temperature for 5 min. The
reaction was then quenched with H2O, extracted twice with
CH2Cl2, dried over MgSO4, filtered, and evaporated under
reduced pressure. The crude product was chromatographed
over silica (EtOAc/hexane, 2:8) to yield two products (4d:
CvC insertion product and 5d: C–Li insertion product).
46%) H NMR (CDCl3): d¼0.83 (t, J¼6.8 Hz, 3H), 1.21–
1.35 (m, 5H), 1.54–1.71 (m, 4H), 1.89 (m, 1H), 1.95–2.12
(m, 6H), 3.98 (brs, 1H), 4.85–4.97 (m, 2H), 5.74 (m, 1H).
13C NMR (CDCl3): d¼14.1, 17.9, 23.1, 29.5, 29.7, 31.7,
32.1, 32.5, 32.6, 67.1, 114.4, 133.2, 134.7, 138.6. HRMS
calcd for C14H24O (Mþ) 208.1827; found 208.1816.
4.4.8. (cis)-6-But-3-enyl-5-methoxy-2-methyl-
bicyclo[3.1.0]hexan-2-ol (4f). (Oil, 24%) 1H NMR
(CDCl3): d¼0.63 (m, 1H), 1.02 (d, J¼3 Hz, 1H), 1.10 (m,
1H), 1.16 (s, 3H), 1.34 (m, 1H), 1.50–1.61 (m, 2H), 1.84
(dd, J¼8, 12 Hz, 1H), 2.07–2.16 (m, 2H), 2.18 (m, 1H),
3.28 (s, 3H), 4.86–4.99 (m, 2H), 5.76 (m, 1H). 13C NMR
(CDCl3): d¼25.1, 25.8, 27.2, 27.5, 33.9, 37.0, 39.8, 55.8,
73.3, 79.2, 114.7, 138.7.
4.4.1. 7-Hydroxy-7-methyl-spiro[2.4]heptan-4-one (4a).
Phenyllithium in Et2O (0.05 M) was used as base in this
case as recently reported.22 The isolated product in this case
is the rearranged spiro cyclopropane product (oil, 88%). 1H
NMR (CDCl3): d¼0.91 (m, 4H), 1.12 (s, 3H), 1.59 (s, OH),
1.98 (m, 1H), 2.11–2.31 (m, 2H), 2.53 (m, 1H). 13C NMR
(CDCl3): d¼12.5, 17.0, 24.9, 36.0, 36.8, 39.8, 76.4, 218.1.
4.4.9. (trans)-6-But-3-enyl-5-methoxy-2-methyl-
bicyclo[3.1.0]hexan-2-ol (4f0). (Oil, 33%) 1H NMR
(CDCl3): d¼1.20 (s, 3H), 1.23–1.55 (m, 5H), 1.84 (m,
1H), 2.02 (dd, J¼7.8, 12.2 Hz, 1H), 2.18 (m, 2H), 2.32 (m,
1H), 3.30 (s, 3H), 4.97–5.08 (m, 2H), 5.85 (m, 1H). 13C
NMR (CDCl3): d¼23.2, 25.7, 26.0, 28.7, 34.8, 39.8, 39.9,
55.4, 73.5, 79.2, 115.0, 138.7.
4.4.2. 1-Butyl-2-methyl-5-vinylcyclopent-2-enol (5a).
1
(Oil, 10%) H NMR (CDCl3): d¼0.82 (t, J¼6.7 Hz, 3H),
1.23 (s, 3H), 1.35–2.45 (m, 10H), 4.99–5.08 (m, 2H), 6.54
(m, 1H). 13C NMR (CDCl3): d¼13.9, 23.3, 24.5, 25.9, 27.9,
33.1, 39.6, 85.2, 114.7, 131.6, 135.5, 146.0.
Acknowledgements
4.4.3. (Z and E)-6-But-3-enyl-2-methyl-7-oxabicyclo-
[4.1.0]heptane (4b). tert-Butyllithium (0.1 M in THF) was
used as base in this case (oil, 61%). The product that results
from SN2 prime nucleophilic attack was obtained as a
mixture of Z and E diastereomers. 1H NMR (CDCl3):
d¼0.87 (s, 9H), 0.89 (s, 9H), 1.37 (s, 2£3H), 1.40–1.78 (m,
2£3H), 1.94 (m, 2£2H), 2.08 (m, 2£1H), 2.15 (m, 2£1H),
2.27 (m, 2£1H), 3.19 (s, 1H), 3.46 (s, 1H), 5.65 (m, 2£1H).
13C NMR (CDCl3): d¼18.8, 20.3, 23.2, 23.6, 29, 3 (2C),
29.5, 30.0, 30.3, 30.7, 31.3, 31.6, 40.7, 41.7, 57.5 (2C), 64.4
(2C), 129.9, 130.3, 133.7, 133.8.
Dr Jerry J. Harnett is gratefully acknowledged for reviewing
this manuscript.
References
1. Gorzynski-Smith, J. Synthesis 1984, 629–656.
2. Lipshutz, B. H.; Koslowski, J.; Wilhelm, R. S. J. Am. Chem.
Soc. 1982, 104, 2305–2307. Reich, H. J.; Sanders, A. W.;
Fiedler, A. T.; Bevan, M. J. J. Am. Chem. Soc. 2002, 124,
13386–13387.
4.4.4. 5-Methoxy-2-methyl-tricyclo[6.1.0.0.3.4]nonan-2-
1
ol (4d). (Oil, 47%) H NMR (CDCl3): d¼0.73 (m, 2H),
3. Buchenan, J. G.; Sable, H. Z. Selective Organic
Transformation; Thyagarajan, B. S., Ed.; Wiley: New York,
1972; Vol. 2, p 1.
0.90 (s, 3H), 1.05 (m, 1H), 1.33–1.45 (m, 2H), 1.63–1.76
(m, 3H), 1.87 (m, 1H), 2.02 (m, 1H), 2.15 (m, 1H), 3.02 (brs,
1H), 3.16 (s, 3H). 13C NMR (CDCl3): d¼7.9, 22.1, 22.7,
25.4, 29.9, 30.1, 40.8, 46.6, 51.8, 78.5, 95.0. HRMS calcd
for C10H15O2 (Mþ2Me) 167.1072; found 167.1089.
4. Simpkins, N. S.; Cox, P. J. Tetrahedron: Asymmetry 1991, 2,
1–26. O’Brien, P. J. O’Brien. Chem. Soc., Perkin Trans. 1
1998, 1439–1458. Eames, J. Eur. J. Org. Chem. 2002,
393–401.
4.4.5. 3-But-3-enyl-2-butyl-1-methylcyclopent-2-enol
1
5. Mordini, A.; Ben Rayana, E.; Margot, C.; Schlosser, M.
Tetrahedron 1990, 46, 2401–2410.
6. Sodergren, M. J.; Anderson, P. G. J. Am. Chem. Soc. 1998,
(5d). (Oil, 26%) H NMR (CDCl3): d¼0.83 (t, J¼7 Hz,
3H), 1.23 (s, 3H), 1.28–1.39 (m, 4H), 1.75–2.07 (m, 9H),